It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
FINGOLIMOD – DANISH COURT GRANTS PI, ALBEIT DISSENTING OPINION FINDS PATENT INVALID DUE TO LACK OF INVENTIVE STEP
-
International Law Talk Podcast: EU Competition Law Developments in the Pharmaceutical Sector with Michael Clancy and David Hull
-
Patent case: Accord Healthcare Ltd. vs. Shire-NPS Pharmaceuticals Inc., Netherlands
-
Patent case: St. Jude Medical LLC v. Snyders Heart Valve LLC, USA
-
Monoclonal NGF-antagonist antibodies/LAY LINE, European Patent Office (EPO Board of Appeal), 04 August 2009
-
The Italian Supreme Court on prior use
-
Unwired Planet v Huawei FRAND judgment
-
Chairman Preparatory Committee is hopeful start Unified Patent Court will not be delayed by Brexit complications
-
German Federal Court of Justice confirms application of Comvik/Hitachi approach
-
NO REIMBURSABLE PRICE FOR GENERICS LAUNCHING AT RISK IN ITALY